About this trial
Supracondylar femur periprosthetic fractures about a total knee arthroplasty (TKA) are a catastrophic and challenging complication of TKA and unfortunately are increasing in incidence. Fixation of these fractures can be challenging due to altered anatomy for the TKA and the presence of the metallic femoral component and have a relatively high complication rate. As a result, some surgeons elect to treat these fractures with a distal femur replacement total knee arthroplasty (DFR). The purpose of this study is to prospectively evaluate periprosthetic femur fractures treated with ORIF or DFR and compare various outcomes measures (Get up and go times, KOOS Jr score)
Eligibility criteria
Qualifiers
English speaking patients
55 years or older with Su Type II or Su Type III periprosthetic femur fractures or OTA/OA 33C or 338/3 native knee distal femur fracturing requiring surgical intervention and are medically fit to undergo surgical intervention
Disqualifiers
Patients with an active total knee prosthetic infection
Patients unable to undergo surgical intervention
Patient with an open fracture
Non-English-speaking patients
Trial design
Treatments tested in this trial
- Timed Up and Go Test on subjects with ORIF of distal femur fractures
- Koos Jr assesment on subjects with ORIF of distal femur fractures
- Timed Up and Go Test on subjects with DFR of distal femur fracture
- Koos Jr assesment on subjects with DFR of distal femur fracture